Details of the Drug

General Information of Drug (ID: DMDTU6I)

Drug Name

TAK-999

Synonyms

fazirsiran

Indication

Disease Entry	ICD 11	Status	REF
Alpha-1 antitrypsin deficiency	5C5A	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

RNAi

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05677971) A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis. U.S.National Institutes of Health.